Skip to main content
Home
    • ALL Specialities ALL Specialities
    Home
    Home

    Lisa Lamotta

    News

    Obesity Drug Resubmitted for FDA Approval

    Author:
    Lisa Lamotta
    Publish date: October 18, 2011

    • Read More

    News

    Cancer Drugs Have Worst Phase III Track Record

    Author:
    Sue Sutter
    Lisa Lamotta
    Publish date: February 16, 2011

    • Read More

    News

    FDA Seeks More Data on Qnexa Side Effects

    Author:
    Lisa Lamotta
    Publish date: December 1, 2010

    • Read More

    News

    FDA Asks for More Data on Weight-Loss Combination Drug Qnexa

    Author:
    Lisa Lamotta
    Publish date: October 29, 2010

    • Read More

    News

    FDA Asks for More Data on Weight-Loss Combination Drug Qnexa

    Author:
    Lisa Lamotta
    Publish date: October 29, 2010

    • Read More

    News

    FDA Rejects Application for Obesity Drug Lorcaserin

    Author:
    Lisa Lamotta
    Publish date: October 25, 2010

    • Read More

    News

    FDA Rejects Application for Obesity Drug Lorcaserin

    Author:
    Lisa Lamotta
    Publish date: October 25, 2010

    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties